Unrecognized myocardial infarction and risk of a trial fibrillation: The Rotterdam study

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1453-1457

  Krijthe, Bouwe P ^a,b   Leening, Maarten J G ^a   Heeringa, Jan ^a   Kors, Jan A ^a   Hofman, Albert ^a   Franco, Oscar H ^a   Witteman, Jacqueline C M ^a   Stricker, Bruno H ^a,b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Genome Initiative (NGI)   (Netherlands)

^c Healthcare Inspectorate   (Netherlands)

Author keywords

Atrial fibrillation; ECG; Epidemiology; Myocardial infarction

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

ATRIAL FIBRILLATION; ECG; EPIDEMIOLOGY; MYOCARDIAL INFARCTION;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84885317678     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.057     Document Type: Article

References (41)

1. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, Incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 2006;27:949-53.
2. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation In elderly subjects (the cardiovascular health study). Am J Cardiol 1994;74:236-41.
3. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation In older adults. Circulation 1997;96:2455-61.
4. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation In a population-based cohort. The framingham heart study. JAMA 1994;271:840-4.
5. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia In a population-based study. The Rotterdam study. Stroke 1997;28:316-21.
6. Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to Incidence and outcome of Ischemic stroke: results from a population-based study. Stroke 2005;36:1115-9.
7. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joInt Influence on mortality: the Framingham heart study. Circulation 2003;107:2920-5.
8. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64.
9. Miyasaka Y, Barnes ME, Bailey KR, et al. Mortality trends In patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol 2007;49:986-92.
10. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 1998;98:946-52.
11. KannelWB, Abbott RD, Savage DD,McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22.
12. de Torbal A, Boersma E, Kors JA, et al. Incidence of recognized and unrecognized myocardial Infarction In men and women aged 55 and older: the Rotterdam study. Eur Heart J 2006;27:729-36.
13. Sheifer SE, Gersh BJ, Yanez III ND, Ades PA, Burke GL, Manolio TA. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial Infarction In the elderly. J Am Coll Cardiol 2000;35:119-26.
14. Boland LL, Folsom AR, Sorlie PD, et al. Occurrence of unrecognized myocardial Infarction In subjects aged 45 to 65 years (the Aric study). Am J Cardiol 2002;90: 927-31.
15. Yano K, MacLean CJ. The Incidence and prognosis of unrecognized myocardial Infarction In the Honolulu, Hawaii, Heart Program. Arch Intern Med 1989;149: 1528-32.
16. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial Infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik study. Ann Intern Med 1995;122:96-102.
17. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial Infarction. An update on the Framingham study. N Engl J Med 1984;311:1144-7.
18. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial Infarction. Ann Intern Med 2001;135:801-11.
19. Hofman A, van Duijn CM, Franco OH, et al. The Rotterdam study: 2012 objectives and design update. Eur J Epidemiol 2011;26:657-86.
20. Kors JA, van Herpen G,Wu J, Zhang Z, Prineas RJ, van Bemmel JH. Validation of a new computer program for Minnesota coding. J ElectroCardiol 1996;29:83-8 [Suppl.].
21. van Bemmel JH, Kors JA, van Herpen G. Methodology of the modular ECG analysis system means. Methods Inf Med 1990;29:346-53.
22. Willems JL, Abreu-Lima C, Arnaud P, et al. The diagnostic performance of computer programs for the Interpretation of electrocardiograms. N Engl J Med 1991;325: 1767-73.
23. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings. Boston: John Wright PSB; 1982. p. 203-20.
24. de Bruyne MC, Mosterd A, Hoes AW, et al. Prevalence, determinants, and misclassification of myocardial Infarction In the elderly. Epidemiology 1997;8: 495-500.
25. Halligan SC, Gersh BJ, Brown Jr RD, et al. The natural history of lone atrial flutter. Ann Intern Med 2004;140:265-8.
26. Lelorier P, Humphries KH, Krahn A, et al. Prognostic differences between atrial fibrillation and atrial flutter. Am J Cardiol 2004;93:647-9.
27. Remme WJ, Swedberg K. Task Force for the D, treatment of chronic heart failure ESoC: guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
28. Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction In the general population; the Rotterdam study. Eur Heart J 1999;20:447-55.
29. van Durme YM, Verhamme KM, Stijnen T, et al. Prevalence, Incidence, and lifetime risk for the development of COPD In the elderly: the Rotterdam study. Chest 2009;135:368-77.
30. Nadelmann J, Frishman WH, Ooi WL, et al. Prevalence, Incidence and prognosis of recognized and unrecognized myocardial Infarction In persons aged 75 years or older: the Bronx aging study. Am J Cardiol 1990;66:533-7.
31. Kannel WB, Cupples LA, Gagnon DR. Incidence, precursors and prognosis of unrecognized myocardial Infarction. Adv Cardiol 1990;37:202-14.
32. Ikram MA, Hollander M, Bos MJ, et al. Unrecognized myocardial Infarction and the risk of stroke: the Rotterdam study. Neurology 2006;67:1635-9.
33. Leening MJ, Elias-Smale SE, Felix JF, et al. Unrecognised myocardial Infarction and long-term risk of heart failure In the elderly: the Rotterdam study. Heart 2010;96: 1458-62.
34. Ikram MA, van Oijen M, de Jong FJ, et al. Unrecognized myocardial Infarction In relation to risk of dementia and cerebral small vessel disease. Stroke 2008;39: 1421-6.
35. Celik S, Erdol C, Baykan M, Kaplan S, Kasap H. Relation between paroxysmal atrial fibrillation and left ventricular diastolic function In patients with acute myocardial Infarction. Am J Cardiol 2001;88:160-2 [A165].
36. Zicha S, Tsuji Y, Shiroshita-Takeshita A, Nattel S. Beta-blockers as antiarrhythmic agents. Handb Exp Pharmacol 2006:235-66.
37. Kobayashi Y, Katoh T, Takano T, Hayakawa H. Paroxysmal atrial fibrillation and flutter associated with acute myocardial Infarction: hemodynamic evaluation In relation to the development of arrhythmias and prognosis. Jpn Circ J 1992;56: 1-11.
38. Zoni Berisso M, Carratino L, Ferroni A, De Caro E, Mela GS, Vecchio C. The relation between supraventricular tachyarrhythmias and left ventricular dysfunction after acute myocardial Infarction. Acta Cardiol 1988;43:689-701.
39. Nishida K, Qi XY, Wakili R, et al. Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion In a chronic canine model. Circulation 2011;123: 137-46.
40. Dunlay SM, Roger VL. Gender differences In the pathoPhysiology, clinical presentation, and outcomes of Ischemic heart failure. Curr Heart Fail Rep 2012;9: 267-76.
41. Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary heart disease. An Investigation of differences In outcome between the sexes according to Initial coronary disease presentation. Circulation 1993;88:2548-55.